[1]
Marchesi, F. et al. 2020. Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study: Ceftolozane-Tazobatam for febrile neutropenia. Mediterranean Journal of Hematology and Infectious Diseases. 12, 1 (Sep. 2020), e2020065. DOI:https://doi.org/10.4084/mjhid.2020.065.